# 參考文獻

<!-- 格式：APA 7th Edition（依第一作者姓氏字母排序）-->
<!-- 內部追蹤表：docs/07_plans/參考文獻追蹤.md -->
<!-- 下載索引：docs/02_literature/Reference_Download_Index.md -->
<!-- 最後更新：2026-02-09（Crossref / PDF 核實後修正版）-->

---

## 英文文獻

Alaa, A. M., Bolton, T., Di Angelantonio, E., Rudd, J. H. F., & van der Schaar, M. (2019). Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. *PLoS ONE*, *14*(5), e0213653. https://doi.org/10.1371/journal.pone.0213653

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C., Jr. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. *Circulation*, *120*(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644

American Diabetes Association. (2025). Standards of care in diabetes—2025. *Diabetes Care*, *48*(Suppl 1).

Chawla, N. V., Bowyer, K. W., Hall, L. O., & Kegelmeyer, W. P. (2002). SMOTE: Synthetic minority over-sampling technique. *Journal of Artificial Intelligence Research*, *16*, 321–357. https://doi.org/10.1613/jair.953

Dinh, A., Miertschin, S., Young, A., & Mohanty, S. D. (2019). A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. *BMC Medical Informatics and Decision Making*, *19*(1), 211. https://doi.org/10.1186/s12911-019-0918-5

Fisher, R. A. (1936). The use of multiple measurements in taxonomic problems. *Annals of Eugenics*, *7*(2), 179–188. https://doi.org/10.1111/j.1469-1809.1936.tb02137.x

He, H., & Garcia, E. A. (2009). Learning from imbalanced data. *IEEE Transactions on Knowledge and Data Engineering*, *21*(9), 1263–1284. https://doi.org/10.1109/TKDE.2008.239

Hung, M.-H., Shih, L.-C., Wang, Y.-C., Leu, H.-B., Huang, P.-H., Wu, T.-C., Lin, S.-J., Pan, W.-H., Chen, J.-W., & Huang, C.-C. (2021). Prediction of masked hypertension and masked uncontrolled hypertension using machine learning. *Frontiers in Cardiovascular Medicine*, *8*, 778306. https://doi.org/10.3389/fcvm.2021.778306

James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Jr., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Jr., Narva, A. S., & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). *JAMA*, *311*(5), 507–520. https://doi.org/10.1001/jama.2013.284427

Kanegae, H., Suzuki, K., Fukatani, K., Ito, T., Harada, N., & Kario, K. (2020). Highly precise risk prediction model for new-onset hypertension using artificial intelligence techniques. *The Journal of Clinical Hypertension*, *22*(3), 445–450. https://doi.org/10.1111/jch.13759

Liu, Y.-Q., Chang, T.-W., Lee, L.-C., Chen, C.-Y., Hsu, P.-S., Tsan, Y.-T., Yang, C.-T., & Chu, W.-M. (2024). Use of machine learning to predict the incidence of type 2 diabetes among relatively healthy adults: A 10-year longitudinal study in Taiwan. *Diagnostics*, *15*(1), 72. https://doi.org/10.3390/diagnostics15010072

Luo, Y., Wu, Q., Meng, R., Lian, F., Jiang, C., Hu, M., Wang, Y., & Ma, H. (2023). Associations of serum uric acid with cardiovascular disease risk factors [Dataset]. *Dryad Digital Repository*. https://doi.org/10.5061/dryad.z08kprrk1

Luo, Y., Wu, Q., Meng, R., Lian, F., Jiang, C., Hu, M., Wang, Y., & Ma, H. (2024). Associations of serum uric acid with cardiovascular disease risk factors: A retrospective cohort study in southeastern China. *BMJ Open*, *13*(9), e073930. https://doi.org/10.1136/bmjopen-2023-073930

Majcherek, D., Ciesielski, A., & Sobczak, P. (2025). AI-driven analysis of diabetes risk determinants in U.S. adults: Exploring disease prevalence and health factors. *PLoS ONE*, *20*(9), e0328655. https://doi.org/10.1371/journal.pone.0328655

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. *Circulation*, *106*(25), 3143–3421. https://doi.org/10.1161/01.CIR.0000038419.01177.FA

Ohira, T., & Iso, H. (2013). Cardiovascular disease epidemiology in Asia: An overview. *Circulation Journal*, *77*(7), 1646–1652. https://doi.org/10.1253/circj.CJ-13-0702

Saito, T., & Rehmsmeier, M. (2015). The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. *PLoS ONE*, *10*(3), e0118432. https://doi.org/10.1371/journal.pone.0118432

Stanciu, S., Rusu, E., Miricescu, D., Radu, A. C., Axinia, B., Vrabie, A. M., Ionescu, R., Jinga, M., & Sirbu, C. A. (2023). Links between metabolic syndrome and hypertension: The relationship with the current antidiabetic drugs. *Metabolites*, *13*(1), 87. https://doi.org/10.3390/metabo13010087

Sun, D., Liu, J., Xiao, L., Liu, Y., Wang, Z., Li, C., Jin, Y., Zhao, Q., & Wen, S. (2017). Recent development of risk-prediction models for incident hypertension: An updated systematic review. *PLoS ONE*, *12*(10), e0187240. https://doi.org/10.1371/journal.pone.0187240

Sun, Z., & Zheng, Y. (2025). Metabolic diseases in the East Asian populations. *Nature Reviews Gastroenterology & Hepatology*, *22*(7), 500–516. https://doi.org/10.1038/s41575-025-01058-8

Tsai, H., Yang, T.-W., Wu, T.-Y., Tu, Y.-C., Chen, C.-L., & Chou, C.-F. (2025). Multitask learning multimodal network for chronic disease prediction. *Scientific Reports*, *15*(1), 15468. https://doi.org/10.1038/s41598-025-99554-z

U.S. Department of Agriculture and U.S. Department of Health and Human Services. (2025). *Dietary Guidelines for Americans, 2025–2030* (10th ed.). https://www.dietaryguidelines.gov/

Wang, C.-C., Chu, T.-W., & Jang, J.-S. R. (2024). Next-visit prediction and prevention of hypertension using large-scale routine health checkup data. *PLoS ONE*, *19*(11), e0313658. https://doi.org/10.1371/journal.pone.0313658

World Health Organization. (2023). *Global report on hypertension: The race against a silent killer*. WHO. https://www.who.int/publications/i/item/9789240081348

World Heart Federation. (2023). *World Heart Report 2023: Confronting the world's number one killer*. WHF. https://world-heart-federation.org/world-heart-report-2023/

Yang, C.-C., Wu, S.-T., Chu, T.-W., Liu, C.-H., & Chuang, Y.-J. (2025). Dual machine learning framework for predicting long-term glycemic change and prediabetes risk in young Taiwanese men. *Diagnostics*, *15*(19), 2507. https://doi.org/10.3390/diagnostics15192507

Ye, C., Fu, T., Hao, S., Zhang, Y., Wang, O., Jin, B., Xia, M., Liu, M., Zhou, X., Wu, Q., Guo, Y., Zhu, C., Li, Y., Culver, D. S., Alfreds, S. T., Stearns, F., Sylvester, K. G., Widen, E., McElhinney, D., & Ling, X. (2018). Prediction of incident hypertension within the next year: Prospective study using statewide electronic health records and machine learning. *Journal of Medical Internet Research*, *20*(1), e22. https://doi.org/10.2196/jmir.9268

Zhao, D. (2021). Epidemiological features of cardiovascular disease in Asia. *JACC: Asia*, *1*(1), 1–13. https://doi.org/10.1016/j.jacasi.2021.04.007

---

## 中文文獻

國民健康署（2022）。*2017–2020 國民營養健康狀況變遷調查*。衛生福利部。https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=3999&pid=15562

國民健康署（2025）。*成人預防保健服務擴大至 30 歲公告*。衛生福利部。https://www.hpa.gov.tw/Pages/detail.aspx?nodeid=4878&pid=18755

---

*備註：本文獻清單共 30 筆（英文 28 筆、中文 2 筆），依 APA 第七版格式排列。*
